FourThought Financial’s iShares Biotechnology ETF IBB Stock Holding History

FourThought Financial’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$45K	Hold	384	–	–	0.01%	641
2022 Q2	$45K	Hold	384	–	–	0.01%	638
2022 Q1	$50K	Sell	384 -90	-19%	-$11.7K	0.01%	660
2021 Q4	$72K	Hold	474	–	–	0.01%	565
2021 Q3	$76K	Buy	474 +90	+23%	+$15.1K	0.01%	561
2021 Q2	$62K	Sell	384 -98	-20%	-$15.1K	0.01%	635
2021 Q1	$72K	Hold	482	–	–	0.01%	582
2020 Q4	$73K	Buy	+482	New	+$68.9K	0.01%	562

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

FourThought Financial's IBB Position: Q3 2022 in Review

FourThought Financial held its iShares Biotechnology ETF (IBB) position steady in Q3 2022 at 384 shares worth $45K. The position accounts for 0.01% of the portfolio, ranked #641.

FourThought Financial first reported a position in IBB in Q4 2020 and has held it in 8 quarters since. The position peaked at $76K in Q3 2021. 830 funds tracked by Wall St. Rank hold IBB as of Q3 2022.

FourThought Financial held 384 shares of iShares Biotechnology ETF worth $45K as of Q3 2022.
FourThought Financial left its iShares Biotechnology ETF share count unchanged in Q3 2022.
iShares Biotechnology ETF made up 0.01% of FourThought Financial's portfolio in Q3 2022, its #641 holding.
FourThought Financial first reported a position in iShares Biotechnology ETF in Q4 2020 and has held it in 8 quarters since.
FourThought Financial's iShares Biotechnology ETF position peaked at $76K in Q3 2021.
830 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2022.

Based on FourThought Financial's 13F filing for Q3 2022, filed 21 Nov 2022.